Overview
EN ISO 11979-8:2017 - "Ophthalmic implants - Intraocular lenses - Part 8: Fundamental requirements" defines the fundamental safety and performance expectations for intraocular lenses (IOLs) intended for surgical implantation into the anterior segment of the human eye. It applies across IOL types but explicitly excludes corneal implants and transplants. This harmonized European standard (CEN endorsement of ISO 11979-8:2017) supports regulatory conformity in the EU and is part of the wider ISO 11979 series for ophthalmic implants.
Key topics and requirements
The standard sets out core requirements and references to specific test methods and processes. Major technical topics include:
- Safety and performance - Demonstration via pre‑clinical and clinical evaluation, supported by documented risk analysis in accordance with ISO 14971 (risk management for medical devices).
- Optical and mechanical properties - Requirements are connected to other parts of the ISO 11979 series that specify test methods for optics and mechanics.
- Biocompatibility - Materials and biological evaluation principles are required (see referenced ISO 11979-5).
- Clinical evaluation - Expectations for clinical evidence and investigation planning (cross‑referenced to ISO 14155 where applicable).
- Manufacturing and sterilization - General manufacturing controls, sterilization methods and bacterial endotoxin considerations.
- Packaging and shelf‑life - Transport stability and shelf‑life testing requirements.
- Labelling, information and documentation - Essential labelling and information for safe use and regulatory documentation for conformity assessment.
The standard is normative in part by cross‑reference to other ISO documents that define specific test methods and validation protocols.
Practical applications
EN ISO 11979-8:2017 is used to:
- Guide IOL design validation and determine what evidence is needed to demonstrate safety and performance.
- Support regulatory submissions and technical files/dossiers for CE marking in the EU (see Annex ZA relationship to Directive 93/42/EEC).
- Define requirements for clinical investigations, sterilization validation, shelf-life studies, labelling and post‑market documentation.
- Inform contracts with suppliers and establish quality controls in manufacturing and sterilization processes.
Who should use this standard
- IOL and ophthalmic device manufacturers
- Regulatory affairs and QA/RA professionals preparing CE/market access documentation
- Clinical researchers and trial sponsors designing IOL clinical studies
- Notified bodies and conformity assessment organizations
- Design engineers and materials specialists responsible for optical, mechanical and biocompatibility performance
Related standards
Key referenced documents (ISO 11979 series and others):
- ISO 11979-1 through -7, -9, -10 (Series for optical, mechanical, biocompatibility, clinical, shelf‑life)
- ISO 14155 (clinical investigation GCP)
- ISO 14630 (non‑active surgical implants)
- ISO 14971 (risk management)
Keywords: EN ISO 11979-8:2017, intraocular lenses, ophthalmic implants, fundamental requirements, IOL standards, clinical evaluation, biocompatibility, sterilization, risk management.
